Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Ethics declarations Conflict of interest MA has received honoraria from Otsuka Pharmaceutical Co., Ltd
242 This suggests that GLP-1R agonists could alleviate the systemic extrapancreatic pathology associated with T2D, 347349 and have more clinical relevance than just improving insulin secretion in patients
As we experience new therapies that come to market at continuously rising costs, we must be good stewards of our member premium dollars that are used to pay for these therapies, explains Tiffany Liesmann, Chief Pharmacist at Blue Cross and Blue Shield of Kansas
PLoS One 15, e0225392e0225321
US$ 27.98
US$ 24.81
US$ 20.25
US$ 20.75
US$ 28.98
